Literature DB >> 18618831

Modeling and optimization of the baculovirus expression vector system in batch suspension culture.

J F Power1, S Reid, K M Radford, P F Greenfield, L K Nielsen.   

Abstract

A mathematical model has been developed that predicts the cell population dynamics and production of recombinant protein and infective extracellular virus progeny by insect cells after infection with baculovirus in batch suspension culture. Infection in the model is based on the rate of virus attachment to suspended insect cells under culture conditions. The model links the events following infection with the sequence of gene expression in the baculovirus replicative cycle. Substrate depletion is used to account for the decrease in product yield observed when infecting at high cell densities. Model parameters were determined in shaker flasks for two media: serum-supplemented IPL-41 medium and serum free Sf900II medium. There was good agreement between model predictions and the results from an independent series of experiments performed to validate the mode. The model predicted: (1) the optimal time of infection at high multiplicity of infection: (2) the timing and magnitude of recombinant protein production in a 2-L bioreactor; and (3) the timing and magnitude of recombinant protein production at multiplicities of infection from 0.01 to 100 plaque-forming units per cell. Through its ability to predict optimal infection strategies in batch suspension culture, the model has use in the design and optimization of large-scale systems for the production of recombinant products using the baculovirus expression vector system.

Year:  1994        PMID: 18618831     DOI: 10.1002/bit.260440607

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  14 in total

1.  Modelling baculovirus infection of insect cells in culture.

Authors:  J F Power; L K Nielsen
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  The indirect effects of multiplicity of infection on baculovirus expressed proteins in insect cells: secreted and non-secreted products.

Authors:  K M Radford; C Cavegn; M Bertrand; A R Bernard; S Reid; P F Greenfield
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

3.  A tubular segmented-flow bioreactor for the infection of insect cells with recombinant baculovirus.

Authors:  Y C Hu; M Y Wang; W E Bentley
Journal:  Cytotechnology       Date:  1997-07       Impact factor: 2.058

4.  Insect cell cultivation: growth and kinetics.

Authors:  G Schmid
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

5.  Optimisation of protein expression and establishment of the Wave Bioreactor for Baculovirus/insect cell culture.

Authors:  Wilfried Weber; Eric Weber; Sabine Geisse; Klaus Memmert
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

6.  In vitro production studies with a wild-type Helicoverpa baculovirus.

Authors:  S Chakraborty; P Greenfield; S Reid
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

7.  Structured modeling of recombinant protein production in batch and fed-batch culture of baculovirus-infected insect cells.

Authors:  J D Jang; C S Sanderson; L C Chan; J P Barford; S Reid
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

8.  Enhancement of Sf9 Cells and Baculovirus Production Employing Grace's Medium Supplemented with Milk Whey Ultrafiltrate.

Authors:  Fabiana R X Batista; Carlos A Pereira; Ronaldo Z Mendonça; Angela M Moraes
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

9.  Titer estimation for quality control (TEQC) method: A practical approach for optimal production of protein complexes using the baculovirus expression vector system.

Authors:  Tsuyoshi Imasaki; Sabine Wenzel; Kentaro Yamada; Megan L Bryant; Yuichiro Takagi
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

10.  Computational Modelling of Large Scale Phage Production Using a Two-Stage Batch Process.

Authors:  Konrad Krysiak-Baltyn; Gregory J O Martin; Sally L Gras
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.